Cencora beats quarterly profit estimates on strong demand for specialty medicines [Yahoo! Finance]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Yahoo! Finance
Cencora is capitalizing on surging demand for high-cost specialty drugs treating rheumatoid ?arthritis and cancer, which are generating strong margins. The company in November said it would invest $1 billion to expand its U.S. network, responding to the Trump administration's onshoring push to encourage localized ?operations and reduce dependence ?on overseas hubs. Cencora said it completed its $5 billion acquisition of OneOncology, which it bought from private investment ?firm TPG in December, deepening its presence in cancer care networks. The company updated its fiscal 2026 forecast to reflect the completion of its ?acquisition of OneOncology, raising adjusted operating income growth expectations ?to 11.5% to 13.5% from a previous range of 8% to 10%. It recorded quarterly revenue of $85.93 billion, falling short of expectations of $86.03 billion. The company's shares were down 5% in premarket trading. Cencora also reaffirmed its full-year adjusted profit forecast of $17.
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora (COR) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Cencora (NYSE:COR) had its price target lowered by analysts at Evercore ISI from $440.00 to $420.00. They now have an "outperform" rating on the stock.MarketBeat
- Cencora Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Cencora (COR) Q1 2026 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates [Yahoo! Finance]Yahoo! Finance
COR
Earnings
- 2/4/26 - Beat
COR
Sec Filings
- 2/4/26 - Form 10-Q
- 2/4/26 - Form 8-K
- 1/30/26 - Form 3
- COR's page on the SEC website